Patents by Inventor Asgar Electricwala

Asgar Electricwala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anticoagulants and their uses
    Publication number: 20040171538
    Abstract: The present invention relates to the identification of a specific inhibitor of the extrinsic clotting pathway from triatomine bugs, which we have designated TEPI (triatomine extrinsic pathway inhibitor).
    Type: Application
    Filed: January 2, 2004
    Publication date: September 2, 2004
    Inventors: Nils Von Sicard, Michael Morris, Asgar Electricwala, Roger Munro
  • Treatment of thrombotic events
    Patent number: 5977056
    Abstract: A method for preventing the formation of platelet-rich clots or thrombus, and for deaggregating platelet-rich clots or thrombus, using hementin, a polypeptide derived from leech salivary glands. Hementin may be administered for this purpose in a pharmaceutically acceptable carrier or excipient, with or without additional anticoagulants such as hirudin, hirudin analogues, or an inhibitor of factor Xa.
    Type: Grant
    Filed: March 27, 1996
    Date of Patent: November 2, 1999
    Assignee: Biopharm (UK) Limited
    Inventors: Christopher Powell-Jones, Roy T. Sawyer, Asgar Electricwala, Anthony Atkinson
  • Anti-thrombins
    Patent number: 5472942
    Abstract: A polypeptide derived from leeches of the species Hirudinaria manillensis has the following amino acid sequence: ##STR1## wherein Xaa indicates any amino acid residue; D indicates Cys or Pro; E indicates Glu, Asp or His; F indicates Asp, Lys or Trp; or a pharmaceutically acceptable salt, derivative or bioprecursor thereof. The polypeptide, and fragments thereof, is a specific anti-thrombin useful as a medicament.
    Type: Grant
    Filed: July 10, 1991
    Date of Patent: December 5, 1995
    Assignee: Biopharm (UK) Limited
    Inventors: Roy Sawyer, Christopher Powell-Jones, Anthony Atkinson, Asgar Electricwala
  • Protease inhibitor
    Patent number: 5397694
    Abstract: This invention relates to a novel protease-inhibitor,--which we called GELIN--and to pharmaceutical and cosmetic preparations thereof, containing this compound. GELIN is an inhibitor of human and porcine leucocyte elastase and chymotrypsin. GELIN has specific antibiotic properties. It also relates to the novel use of EGLIN, another chymotrypsin-inhibitor in cosmetic preparations.
    Type: Grant
    Filed: October 24, 1991
    Date of Patent: March 14, 1995
    Assignee: Merck Patent GmbH
    Inventors: Anthony Atkinson, Asgar Electricwala, Roy T. Sawyer, Nils von Sicard, Gerard Voerman
  • Fibrinolytic enzymes produced from established non-cancerous cell lines
    Patent number: 4780412
    Abstract: Fibrinolytic enzymes are produced and then isolated from non-cancerous established cell lines, designated as BEB or GPK. These fibrinolytic enzymes differ from those produced by malignant cell lines.
    Type: Grant
    Filed: November 4, 1983
    Date of Patent: October 25, 1988
    Assignee: Public Health Lab Svc Bd. University Coll.
    Inventors: Anthony Atkinson, Asgar Electricwala, John B. Griffiths, Amy Latter, Patrick A. Riley, Peter M. Sutton